Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Theranostic Translation Applications Against Viral, Metabolic Liver Diseases and Hepatic Oncogenesis: Lipoprotein and Apolipoproteins at a Crossroad

NCT03220971 is registered in ClinicalTrials.gov with Chun-Hsiang Wang as lead sponsor.

NCT NCT03220971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03220971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Theranostic Translation Applications Against Viral, Metabolic Liver Diseases and Hepatic Oncogenesis: Lipoprotein and Apolipoproteins at a Crossroad
Lead sponsor
Chun-Hsiang Wang
Phase
Observational
Overall status
Unknown status
Start date
September 20, 2017
Completion date
October 31, 2019
Enrollment
440 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorders of lipoprotein metabolism and other lipidaemias